
Blogs

100 for Parkinson’s study

This study was designed to help participants learn more about their own health, better understand how technology can support people living with Parkinson’s, and build a research dataset to drive new insights.
Three questions with Kristine Klinger

In the latest in our ‘Three questions with’ series, Chief Delivery Officer Kristine Klinger shares her vision for uMotif’s services delivery organization and our culture of continuous delivery improvement. Kristine also provides some practical advice for companies interested in incorporating eCOA/ePRO technology.


Guidance on use of Patient Experience Data in Real World studies – EU Perspectives

Patient insights are expected to become increasingly instrumental in optimising medicine development and regulatory decision making.
uMotif eCOA/ePRO Platform Helps to Expand Understanding of Hypoglycaemic Events

Patient engagement expert and uMotif sales leader Peter Robinson shares insight at the 2023 International Conference on Advanced Technologies & Treatments for Diabetes (ATTD) – Feb. 22-25, Berlin.


Three questions with Julia Lakeland

In the latest in our ‘Three questions with’ series, Chief Product Officer, Julia Lakeland discusses current trends in the eCOA/ePRO industry and how sponsors and regulators can improve patient engagement.
CNS Summit 2022 Boca was buzzing with patient-centricity

Our Chief Patient Office Bruce Hellman attended the CNS Summit held in Boca Raton, Florida and discovered that true patient centricity is the way forward for patient trials.


ISPOR 2022 – The continued rise of the Patient Reported Outcome

Bruce Hellman Chief Patient Officer reflects on his key learnings from this year’s ISPOR assembly on the future of the life sciences industry.
Digital Era Expands Scope and Impact for Medical Affairs. Prepare to Rise to the Challenge

With the rise of digital technology expanding the role of Medical Affairs, our Chief Product Officer, Julia Lakeland explains how Medical Affairs has a critical role to play in serving as the bridge between patients and pharmaceutical companies to ensure patient safety and improve outcomes.


Three things I learned at the PCMG 2022 assembly – “ The ‘I’ of the Storm”

Bruce Hellman reflects on his time at this year’s ISPOR—The Professional Society for Health Economics and Outcomes Research conference.